Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.60
Bid: 3.60
Ask: 4.18
Change: -0.08 (-2.17%)
Spread: 0.58 (16.111%)
Open: 3.60
High: 3.60
Low: 3.60
Prev. Close: 3.68
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Commercial Distribution Agreements

14 Dec 2016 07:00

RNS Number : 7736R
Plant Health Care PLC
14 December 2016
 

PLANT HEALTH CARE PLC

 

("Plant Health Care", "PHC" or the "Company")

 

New Commercial Distribution Agreements

Plant Health Care® (AIM: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce four new commercial distribution arrangements, which together represent important progress in driving sales growth in 2017 and beyond.

 

- Plant Health Care has reached agreement with Talc U.S.A. to launch Inceptive™, a novel product containing PHC's patented Harpin 𝜶β technology, which will be mixed with a Talc U.S.A. seed lubricant for corn seed treatment in the USA. Inceptive has been shown in replicated trials to bring substantial benefits on corn such as improved vigour, heightened defense responses and increased yield. This agreement will provide PHC with additional access to the 90 million acre corn market in the USA.

 

- Plant Health Care conducted a product demonstration programme, in conjunction with the Florida Fruit & Vegetable Association, to promote the use of PHC's Employ® product (containing PHC's patented Harpin 𝜶β technology), aimed at reducing the impact of fruit drop in the presence of citrus greening, caused by the Huang Long Bing (HLB) bacterium. This disease has caused devastating damage in citrus in Florida over the last four years, with up to 80% of trees across the state reported as affected. Use of Employ has been shown in replicated trials to reduce losses by more than 10% in the presence of citrus trees infected by HLB. Based on these encouraging results, PHC will be distributing Employ in Florida directly with regional distributors.

 

- Plant Health Care has reached agreement with EDAF Unipessoal LDA, to distribute Plant Health Care's proprietary ProAct® and Myconate® products in Portugal.

 

- Plant Health Care continues to build on its recent success in South Africa with its Harpin 𝜶β and Myconate products and is now preparing to expand distribution to 23 countries in sub-Saharan Africa through its distribution agreement with DuxAgri (Pty) Ltd. Plant Health Care is creating significant momentum in the region by concentrating sales to higher value crops, such as sugar cane, vegetables, citrus, pears and macadamia nuts which all receive multiple product applications per year.

 

Dr Chris Richards, Executive Chairman and Interim CEO of Plant Health Care, commented: "Over the last three years, we have steadily built compelling evidence of the efficacy of products based on the Company's patented Harpin technology. The distribution arrangements announced today reflect further progress in developing sales of the product in significant markets. We expect that these agreements, together with other projects in progress, will drive strong sales growth of products based on Harpin over the coming years."

 

Enquiries:

 

Plant Health Care plcDr Chris Richards, Executive Chairman and Interim CEOTel: +44 1837 880083

 

Liberum Capital - Nomad and BrokerClayton Bush / Chris ClarkeTel: +44 (0) 20 3100 2000

Company website: www.planthealthcare.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLXLLFQLFFFBE
Date   Source Headline
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.